ALX
ALEXANDERS INC
$265.73
+2.76%
$1.4B
No data for this timeframe.
Vol
Market Cap$1.4B
Cap SizeSmall Cap
Inst. Holders9 funds
Inst. Value$104.4M
Inst. Activity6 buys / 3 sells
SEC Reports4
Press Releases3
Recent Activity
May 28, 2026
Press
Alexander's, Inc. completed the sale of its Rego Park I property in Queens, NY to Northwell Health for a gross price of
Impact 5/10
May 28, 2026
contract
Alexander’s Completes Sale of Rego Park I
<p align="justify">PARAMUS, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) a
May 21, 2026
SEC
Alexanders Inc. held its 2026 Annual Meeting on May 21, 2026, where shareholders approved the adoption of the 2026 Omnib
8-K — Impact 2/10
May 21, 2026
Insider
Puri Mandakini sold 505 shares
Director @ $0.00 ($0.00)
May 21, 2026
Insider
SILVERSTEIN WENDY sold 505 shares
Director @ $0.00 ($0.00)
May 21, 2026
Insider
WIGHT RUSSELL B JR sold 505 shares
Director @ $0.00 ($0.00)
May 4, 2026
SEC
Alexander's, Inc. reported Q1 2026 FFO of $2.60 per diluted share, down 36% from $4.06 in Q1 2025, and net income fell t
PRESS-RELEASE — Impact 7/10
Apr 21, 2026
SEC
Analysis based on filing metadata only — document content was unavailable. The press release announces an upcoming earni
PRESS-RELEASE — Impact 3/10
Price Targets
Historical data — last covering-analyst action Aug 2024. No current recommendation available.
$190.00 (Aug 2024)
Current $265.84
Low $190.00
Median $190.00
High $190.00
1 analysts
$190.00
$190.00
Analyst Ratings
0Strong Buy
0Buy
2Hold
5Sell
1Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 6, 2024 | Piper Sandler | MAINTAIN | Underweight → Underweight |
| Jul 22, 2024 | Piper Sandler | MAINTAIN | Underweight → Underweight |
| May 13, 2024 | Piper Sandler | MAINTAIN | Underweight → Underweight |
| Oct 7, 2022 | Piper Sandler | MAINTAIN | Underweight |
| Feb 23, 2015 | Piper Sandler | UPGRADE | Hold → Buy |
Latest Reports
NEUTRAL
Press
5/10
Alexander's, Inc. completed the sale of its Rego Park I property in Queens, NY to Northwell Health for a gross price of
May 28, 2026
NEUTRAL
8-K
2/10
Alexanders Inc. held its 2026 Annual Meeting on May 21, 2026, where shareholders approved the adoption of the 2026 Omnib
May 21, 2026
BEARISH
PRESS-RELEASE
7/10
Alexander's, Inc. reported Q1 2026 FFO of $2.60 per diluted share, down 36% from $4.06 in Q1 2025, and net income fell t
May 4, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $43.5M | TRIM |
| MORGAN STANLEY | $36.9M | DOUBLED |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $8.8M | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $7.1M | TRIM |
| NORGES BANK | $6.2M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 21, 2026 | Puri Mandakini | A | $0.00 |
| May 21, 2026 | SILVERSTEIN WENDY | A | $0.00 |
| May 21, 2026 | WIGHT RUSSELL | A | $0.00 |
| May 21, 2026 | MANDELBAUM DAVID | A | $0.00 |
| May 21, 2026 | ROTH STEVEN | A | $0.00 |
9 institutional holders with $104.4M total value (478,870 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net buying activity: 6 institutions added/increased vs 3 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 199,629 | $43.5M | 41.7% | TRIM -34.9% |
| 2 | MORGAN STANLEY | 169,491 | $36.9M | 35.4% | DOUBLED +608.8% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 40,218 | $8.8M | 8.4% | ADD +29.1% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 32,726 | $7.1M | 6.8% | TRIM -32.3% |
| 5 | NORGES BANK | 28,500 | $6.2M | 6.0% | NEW |
| 6 | TWO SIGMA INVESTMENTS, LP | 2,600 | $566.6K | 0.5% | NEW |
| 7 | BANK OF AMERICA CORP /DE/ | 2,574 | $561.0K | 0.5% | ADD +48.8% |
| 8 | WELLS FARGO & COMPANY/MN | 2,355 | $513.3K | 0.5% | ADD +78.0% |
| 9 | FMR LLC | 777 | $169.3K | 0.2% | TRIM -26.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | TRIM | 306,839 | 199,629 | -34.9% | $43.5M | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 23,914 | 169,491 | +608.8% | $36.9M | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 31,151 | 40,218 | +29.1% | $8.8M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 48,326 | 32,726 | -32.3% | $7.1M | 2025-Q4 |
| NORGES BANK | NEW | — | 28,500 | — | $6.2M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 2,600 | — | $566.6K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 1,730 | 2,574 | +48.8% | $561.0K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 1,323 | 2,355 | +78.0% | $513.3K | 2025-Q4 |
| FMR LLC | TRIM | 1,062 | 777 | -26.8% | $169.3K | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 17,487 | 31,151 | +78.1% | $7.3M | 2025-Q3 |
| UBS Group AG | DOUBLED | 8,299 | 23,405 | +182.0% | $5.5M | 2025-Q3 |
| FMR LLC | TRIM | 2,890 | 1,062 | -63.3% | $249.0K | 2025-Q3 |
| NORGES BANK | EXIT | 2,315 | 0 | -100.0% | $0.00 | 2025-Q3 |
| FMR LLC | TRIM | 3,917 | 2,890 | -26.2% | $651.2K | 2025-Q2 |
| NORGES BANK | NEW | — | 2,315 | — | $521.6K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 3,688 | 2,235 | -39.4% | $503.6K | 2025-Q2 |
| UBS Group AG | ADD | 6,819 | 10,381 | +52.2% | $2.2M | 2025-Q1 |
| NORGES BANK | EXIT | 6,495 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | EXIT | 3,417 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 2,394 | 6,819 | +184.8% | $1.4M | 2024-Q4 |
| CITADEL ADVISORS LLC | NEW | — | 3,417 | — | $683.6K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 662 | 1,004 | +51.7% | $200.8K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 22,149 | — | $5.4M | 2024-Q3 |
7 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 21, 2026 | Puri Mandakini | Director | A | 505 | $0.00 | $0.00 |
| May 21, 2026 | SILVERSTEIN WENDY | Director | A | 505 | $0.00 | $0.00 |
| May 21, 2026 | WIGHT RUSSELL B JR | Director | A | 505 | $0.00 | $0.00 |
| May 21, 2026 | MANDELBAUM DAVID | Director | A | 505 | $0.00 | $0.00 |
| May 21, 2026 | ROTH STEVEN | CHAIRMAN AND CEO | A | 505 | $0.00 | $0.00 |
| May 21, 2026 | DIBENEDETTO THOMAS R | Director | A | 505 | $0.00 | $0.00 |
| May 21, 2026 | SONNENBLICK ARTHUR | Director | A | 505 | $0.00 | $0.00 |
4 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 3 neutral. Avg impact: 3.8/10.
NEUTRAL
8-K
2/10
Alexanders Inc. held its 2026 Annual Meeting on May 21, 2026, where shareholders approved the adopti
May 21, 2026
BEARISH
PRESS-RELEASE
7/10
Alexander's, Inc. reported Q1 2026 FFO of $2.60 per diluted share, down 36% from $4.06 in Q1 2025, a
May 4, 2026
NEUTRAL
PRESS-RELEASE
3/10
Analysis based on filing metadata only — document content was unavailable. The press release announc
Apr 21, 2026
NEUTRAL
DEFA14A
3/10
ALEXANDERS, INC. is holding its 2026 Annual Meeting to vote on director elections, approval of a new
Apr 7, 2026
NEUTRAL
5/10
Alexander's, Inc. completed the sale of its Rego Park I property in Queens, NY to Northwell Health f
May 28, 2026
NEUTRAL
2/10
Alexander's, Inc. declared a regular quarterly dividend of $4.50 per share, consistent with prior qu
Apr 29, 2026
BULLISH
7/10
Alexander's, Inc. (ALX) announced the sale of its Rego Park I property to Northwell Health for $235.
Mar 9, 2026
Historical analyst distribution (last covering-analyst action Aug 2024): 0% buy across 8 analysts — 0 strong buy, 0 buy, 2 hold, 5 sell, 1 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Aug 2024. No current recommendation available.
$190.00 mean target (Aug 2024)
$190.00 Low
$190.00 High
| Metric | Value |
|---|---|
| Current Price | $265.84 |
| Target Low | $190.00 |
| Target Mean | $190.00 |
| Target Median | $190.00 |
| Target High | $190.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 4.7% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 0.9% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 1.3% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 1.7% | — |
1 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Aug 6, 2024 | Piper Sandler | MAINTAIN | Underweight | Underweight |
| Jul 22, 2024 | Piper Sandler | MAINTAIN | Underweight | Underweight |
| May 13, 2024 | Piper Sandler | MAINTAIN | Underweight | Underweight |
| Oct 7, 2022 | Piper Sandler | MAINTAIN | — | Underweight |
| Feb 23, 2015 | Piper Sandler | UPGRADE | Hold | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 2 | 5 | 1 | 0% | |
| May 1, 2026 | 0 | 0 | 2 | 5 | 1 | 0% | |
| Apr 1, 2026 | 0 | 0 | 2 | 5 | 1 | 0% | |
| Mar 1, 2026 | 0 | 0 | 2 | 5 | 1 | 0% | |
| Feb 1, 2026 | 0 | 0 | 2 | 5 | 1 | 0% | |
| Jan 1, 2026 | 0 | 0 | 2 | 5 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 28, 2026
contract
Alexander’s Completes Sale of Rego Park I
<p align="justify">PARAMUS, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) announced today that it has completed the previousl
May 4, 2026
earnings
Alexander’s Announces First Quarter Financial Results
<p align="justify">PARAMUS, N.J., May 04, 2026 (GLOBE NEWSWIRE) -- ALEXANDER’S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quar
May 4, 2026
earnings_calendar
ALX Q1 2026 Earnings Scheduled — 2026-05-04
Apr 29, 2026
dividend
Alexander’s Declares Quarterly $4.50 Dividend on Common Shares
<p align="justify">PARAMUS, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) today announced that its Board of Directors has d
Apr 21, 2026
earnings
Alexander’s Announces First Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
<p align="justify">PARAMUS, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) today announced that it will file its quarterly r
Mar 9, 2026
contract
Alexander’s to Sell Rego Park I for Net Proceeds of $202 Million
<p align="justify">PARAMUS, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) announced today that it has entered into an agree